Batavia Biosciences107Batavia Biosciences is a science driven CDMO in all stages of process development and cGMP manufacturing for viral vaccines, viral vectors and recombinant proteins. We have ample experience in working with adeno-, AAV-, lenti-, gammaretro-, VSV-, measles-, and exotic viruses.
Batavia Biosciences significantly contributes to ease human suffering from infectious diseases, cancer, and rare diseases by leveraging our innovative technologies and in-depth know-how. We do this for viral vaccines and cell and gene therapies at all stages of the development trajectory, from the transition into early clinical studies, to navigating late-stage clinical development and entering commercial manufacturing at higher speed, reduced costs, and with increased success.
The company operates state-of-the-art development and manufacturing facilities in Europe and the US and, as part of the CJ CheilJedang global family, is building a strong position in global health with its strategic partners worldwide.
Batavia Biosciences provide services for viral vector, viral vaccine and recombinant proteins from process development to cGMP manufacturing.
The services include:
- viral vector and protein expression vector construction
- generation of viral vaccine seed stocks
- mammalian cell line generation
- transient protein production
- upstream and downstream process optimization
- medium development
- scale-up development
- assay development
- product characterization
- preclinical manufacturing
- clinical manufacturing
- commercial manufacturing
.
